发明名称 Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
摘要 The present invention is directed to novel substituted bicyclic aromatic compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
申请公布号 US9249132(B2) 申请公布日期 2016.02.02
申请号 US201113991973 申请日期 2011.12.16
申请人 Nivalis Therapeutics, Inc. 发明人 Sun Xicheng;Qiu Jian;Stout Adam
分类号 C07D417/10;C07D215/20;C07D217/16;C07D239/34;C07D241/42;C07D253/10;C07D401/04;C07D403/10;C07D405/04;C07D409/04;C07D413/10;C07C65/105;C07C65/24;C07D213/79;C07D239/28;C07D241/24;C07D295/155;C07D215/06;C07D239/74;C07D409/14;C07D215/60;C07D239/26;C07D401/10;C07D217/04 主分类号 C07D417/10
代理机构 Swanson & Bratschun, L.L.C. 代理人 Swanson & Bratschun, L.L.C.
主权项 1. The compound of Formula 1: wherein R1 is selected from the group consisting of H, F, and Cl; R2a and R2b are independently selected from the group consisting of H, F, Cl, Br, Me, OCH3, and cyano; R2c is selected from the group consisting of H, F, Cl, Br, Me, and OCH3; X is selected from the group consisting of A is selected from the group consisting of R3 is selected from the group consisting of F, Cl, Br, CH3, CF3, OCH3,cyano, N(CH3)2, and morpholino; n is selected from the group consisting of 0, 1, and 2; R4 is selected from the group consisting of H, F, Cl, Br, CH3, CF3, OCH3, cyano, N(CH3)2, and morpholino; with the proviso that when X is  and A is COOH, then at least one of R1, R2a, R2b, R2c, and R4 is not hydrogen, or n must be >0, and R3 when meta to naphthalene, cannot be CH3.
地址 Boulder CO US